114 related articles for article (PubMed ID: 17662609)
21. The UDP-Galp mutase catalyzed isomerization: synthesis and evaluation of 1,4-anhydro-beta-D-galactopyranose and its [2.2.2] methylene homologue.
Sadeghi-Khomami A; Forcada TJ; Wilson C; Sanders DA; Thomas NR
Org Biomol Chem; 2010 Apr; 8(7):1596-602. PubMed ID: 20237670
[TBL] [Abstract][Full Text] [Related]
22. [Synthesis of 2-acetamido-1,4-imino-1,2,4-tridesoxy-D-galactitol and competitive inhibition of human lysosomal beta-hexosaminidase A].
Liessem B; Giannis A; Sandhoff K; Nieger M
Carbohydr Res; 1993 Dec; 250(1):19-30. PubMed ID: 8143290
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and analysis of substrate analogues for UDP-galactopyranose mutase: implication for an oxocarbenium ion intermediate in the catalytic mechanism.
Itoh K; Huang Z; Liu HW
Org Lett; 2007 Mar; 9(5):879-82. PubMed ID: 17266324
[TBL] [Abstract][Full Text] [Related]
24. A Second, Druggable Binding Site in UDP-Galactopyranose Mutase from Mycobacterium tuberculosis?
Shi Y; Colombo C; Kuttiyatveetil JR; Zalatar N; van Straaten KE; Mohan S; Sanders DA; Pinto BM
Chembiochem; 2016 Dec; 17(23):2264-2273. PubMed ID: 27653508
[TBL] [Abstract][Full Text] [Related]
25. Identification of eukaryotic UDP-galactopyranose mutase inhibitors using the ThermoFAD assay.
Martín Del Campo JS; Eckshtain-Levi M; Sobrado P
Biochem Biophys Res Commun; 2017 Nov; 493(1):58-63. PubMed ID: 28919416
[TBL] [Abstract][Full Text] [Related]
26. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
[TBL] [Abstract][Full Text] [Related]
27. Identification of inhibitors of UDP-galactopyranose mutase
Fu J; Fu H; Xia Y; N'Go I; Cao J; Pan W; Vincent SP
Org Biomol Chem; 2021 Mar; 19(8):1818-1826. PubMed ID: 33565547
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of novel pyrrolidine 3,4-diol derivatives as inhibitors of alpha-L-fucosidases.
Moreno-Clavijo E; Carmona AT; Vera-Ayoso Y; Moreno-Vargas AJ; Bello C; Vogel P; Robina I
Org Biomol Chem; 2009 Mar; 7(6):1192-202. PubMed ID: 19262940
[TBL] [Abstract][Full Text] [Related]
29. New classes of potent and bioavailable human renin inhibitors.
Remen L; Bezençon O; Richard-Bildstein S; Bur D; Prade L; Corminboeuf O; Boss C; Grisostomi C; Sifferlen T; Strickner P; Hess P; Delahaye S; Treiber A; Weller T; Binkert C; Steiner B; Fischli W
Bioorg Med Chem Lett; 2009 Dec; 19(23):6762-5. PubMed ID: 19853442
[TBL] [Abstract][Full Text] [Related]
30. Difluoromethylenated polyhydroxylated pyrrolidines: facile synthesis, crystal structure and biological evaluation.
Wang RW; Xu J; Lopez O; Bols M; Qing FL
Future Med Chem; 2009 Aug; 1(5):991-7. PubMed ID: 21426093
[TBL] [Abstract][Full Text] [Related]
31. Enzymatic synthesis of UDP-galactofuranose and an assay for UDP-galactopyranose mutase based on high-performance liquid chromatography.
Lee R; Monsey D; Weston A; Duncan K; Rithner C; McNeil M
Anal Biochem; 1996 Nov; 242(1):1-7. PubMed ID: 8923956
[TBL] [Abstract][Full Text] [Related]
32. The 'mirror-image' postulate as a guide to the selection and evaluation of pyrrolidines as α-l-fucosidase inhibitors.
Stocker BL; Jongkees SA; Win-Mason AL; Dangerfield EM; Withers SG; Timmer MS
Carbohydr Res; 2013 Feb; 367():29-32. PubMed ID: 23295913
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of all-cis 2,5-imino-2,5-dideoxy-fucitol and its evaluation as a potent fucosidase and galactosidase inhibitor.
Ak A; Prudent S; LeNouën D; Defoin A; Tarnus C
Bioorg Med Chem Lett; 2010 Dec; 20(24):7410-3. PubMed ID: 21050758
[TBL] [Abstract][Full Text] [Related]
34. Tetrafluorination of sugars as strategy for enhancing protein-carbohydrate affinity: application to UDP-Galp mutase inhibition.
N'Go I; Golten S; Ardá A; Cañada J; Jiménez-Barbero J; Linclau B; Vincent SP
Chemistry; 2014 Jan; 20(1):106-12. PubMed ID: 24311368
[TBL] [Abstract][Full Text] [Related]
35. Convergent, stereoselective syntheses of the glycosidase inhibitors broussonetines D and M.
Ribes C; Falomir E; Murga J; Carda M; Alberto Marco J
Org Biomol Chem; 2009 Apr; 7(7):1355-60. PubMed ID: 19300820
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of 4-amino-4,5-dideoxy-L-lyxofuranose derivatives and their evaluation as fucosidase inhibitors.
Chevrier C; Le Nouën D; Defoin A; Tarnus C
Carbohydr Res; 2011 Jul; 346(10):1202-11. PubMed ID: 21550024
[TBL] [Abstract][Full Text] [Related]
37. Revised structures of epohelmins A and B isolated as lanosterol synthase inhibitors from a fungal strain FKI-0929.
Shibuya M; Snider BB; Sakano Y; Tomoda H; Omura S; Ebizuka Y
J Antibiot (Tokyo); 2005 Sep; 58(9):599-601. PubMed ID: 16320765
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and fucosidase inhibitory study of unnatural pyrrolidine alkaloid 4-epi-(+)-codonopsinine.
Kotland A; Accadbled F; Robeyns K; Behr JB
J Org Chem; 2011 May; 76(10):4094-8. PubMed ID: 21495694
[TBL] [Abstract][Full Text] [Related]
39. Preliminary studies on the transformation of nitrosugars into branched chain iminosugars: synthesis of 1,4-dideoxy-4-C-hydroxymethyl-1,4-imino-pentanols.
Otero JM; Soengas RG; Estévez JC; Estévez RJ; Watkin DJ; Evinson EL; Nash RJ; Fleet GW
Org Lett; 2007 Feb; 9(4):623-6. PubMed ID: 17286369
[TBL] [Abstract][Full Text] [Related]
40. Deleterious Consequences of UDP-Galactopyranose Mutase Inhibition for Nematodes.
Winton VJ; Justen AM; Deng H; Kiessling LL
ACS Chem Biol; 2017 Sep; 12(9):2354-2361. PubMed ID: 28732158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
